TSHA logo

Taysha Gene Therapies (TSHA) EV/EBITDA

TSHA EV/EBITDA

-10.76
0.000.00%

Thu, 23 Jan 2025 00:15:25 GMT

TSHA EV/EBITDA Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TSHA EV/EBITDA Performance

PeriodPeriodEV/EBITDAEV/EBITDA
todaytoday0.0%
1 m1 month+22.8%
3 m3 months+25.9%
6 m6 months-263.5%
ytdytd+12.2%
1 y1 year-466.3%
5 y5 years-

TSHA EV/EBITDA High & Low

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month-10.76at high-15.92+32.4%
3 m3-month-8.09-33.0%-27.82+61.3%
6 m6-month-2.54-323.6%-27.82+61.3%
1 y1-year-1.79-501.1%-27.82+61.3%
3 y3-year-0.09<-9999.0%-27.82+61.3%
5 y5-year-0.09<-9999.0%-31.19+65.5%
alltimeall time-0.09<-9999.0%-31.19+65.5%

Taysha Gene Therapies EV/EBITDA History

DateValue
2025
-10.76(-12.2%)
2024
-12.25(+412.6%)
2023
-2.39(+236.6%)
DateValue
2022
-0.71(-66.2%)
2021
-2.10(-83.2%)
2020
-12.52

FAQ

  • What is Taysha Gene Therapies EV/EBITDA?
  • What is the all time high EV/EBITDA for Taysha Gene Therapies?
  • What is TSHA EV/EBITDA year-to-date change?
  • What is Taysha Gene Therapies EV/EBITDA year-on-year change?

What is Taysha Gene Therapies EV/EBITDA?

The current EV/EBITDA of TSHA is -10.76

What is the all time high EV/EBITDA for Taysha Gene Therapies?

Taysha Gene Therapies all-time high EV/EBITDA is -0.09

What is TSHA EV/EBITDA year-to-date change?

Taysha Gene Therapies EV/EBITDA has changed by +1.49 (+12.16%) since the beginning of the year

What is Taysha Gene Therapies EV/EBITDA year-on-year change?

Over the past year, TSHA EV/EBITDA has changed by -8.86 (-466.32%)